Beijing: China is advancing the development of Covid-19 vaccines against variants of the novel coronavirus and experiments have shown the inactivated vaccines currently used in the country are effective against them.
Zhang Yuntao, vice-president of China National Biotech Group, a subsidiary of state-owned pharmaceutical giant Sinopharm, told a news conference on Sunday that researchers had been testing the antiviral-mutation ability of the inactivated vaccines.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
